Your browser doesn't support javascript.
loading
A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China.
Li, Hong-Xing; Dong, Mei; Peng, Xiao-Xiao; Liu, Yi-Zhe; Wang, Han; Li, Chao; Du, Yi-Yi; Zhang, Kai; Zong, Qiang.
  • Li HX; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Dong M; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Peng XX; Department of Stomatology, Dongying District People's Hospital, Dongying, Shandong, China.
  • Liu YZ; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Wang H; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Li C; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Du YY; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Zhang K; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Zong Q; Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Front Neurol ; 14: 1103164, 2023.
Article en En | MEDLINE | ID: mdl-36891473
ABSTRACT

Background:

Although Parkinson's disease (PD) is the second most common neurodegenerative disorder, pregnancy in patients with PD is a relatively rare occurrence because the most common age of onset of PD is beyond the childbearing age, except in patients with Young-Onset PD (YOPD) caused by parkin RBR E3 ubiquitin protein ligase (PRKN) mutations. Case In this study, we report the case of a 30-year-old Chinese woman who was affected by PRKN-associated YOPD and was treated with levodopa/benserazide during pregnancy. She gave birth to a healthy baby boy with an Apgar score of 9 through an uncomplicated vaginal delivery.

Conclusion:

This case further suggests that levodopa/benserazide during pregnancy is safe in the treatment of PRKN-associated YOPD.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article